3Global Centrifugal Blood Pump Market - By Type: Disposable Centrifugal Pumps, Reusable Centrifugal Pumps; By Application: Cardiopulmonary Bypass, ECMO (Extracorporeal Membrane Oxygenation), Ventricular Assist Devices (VAD), Other Circulatory Support Applications; By End User: Hospitals, Cardiac Centers, Ambulatory Surgical Centers (ASCs), Specialty Clinics; By Region: North America, Europe, Asia-Pacific Latin America and Others
1 | Market Overview
The global centrifugal blood pump market is experiencing significant growth, fueled by rising demand for mechanical circulatory support in cardiac surgeries, extracorporeal membrane oxygenation (ECMO), and ventricular assist device (VAD) procedures. Centrifugal blood pumps are essential for maintaining blood flow during cardiopulmonary bypass, offering benefits such as reduced blood trauma, decreased hemolysis, and better patient outcomes.
The market is driven by the increasing rates of cardiovascular diseases, improvements in minimally invasive cardiac procedures, and the rising use of ECMO support during critical care, including respiratory failure and severe cardiac conditions. Technological advancements in pump design, biomaterials, and magnetically levitated impellers are also driving growth.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
0.62 |
Historical benchmark |
|
2024 |
1.01 |
Five-year CAGR 10.2% |
|
2031 |
2.32 |
Seven-year CAGR 12.3% |
The market is projected to more than double by 2031, driven by the expansion of cardiac care infrastructure and rising ECMO utilization.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The centrifugal blood pump market is moderately consolidated, with key players offering advanced pump technologies for both short-term and long-term applications.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Abbott Laboratories |
24% |
CentriMag™ Acute Circulatory Support System |
|
Medtronic |
19% |
Bio-Pump® centrifugal blood pump systems |
|
Terumo Corporation |
16% |
Capiox® centrifugal pump series |
|
Getinge Group |
13% |
Rotaflow® II centrifugal pump |
|
Others (LivaNova, Fresenius, regional OEMs) |
28% |
ECMO support pumps, specialized devices |
6 | Market Segmentation
By Type:
By Application:
By End User:
By Region:
7 | Strategic Outlook
The centrifugal blood pump market will develop with AI-enabled pump monitoring, portable ECMO devices, and improved biocompatible materials. Growth prospects include expanding cardiac care in emerging markets, advancing home-based circulatory support systems, and enhancing long-term patient management.
Need help?
Chat with our team in a minute.